Article Link: Brilinta Approved in the US to Reduce the Risk of a First Heart Attack or Stroke in High-Risk Patients with Coronary Artery Disease ...
FDA Approves Oriahnn (elagolix/estradiol/norethindrone acetate and elagolix) for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-Menopausal Women
Article Link: FDA Approves Oriahnn (elagolix/estradiol/norethindrone acetate and elagolix) for the Management of Heavy Menstrual Bleeding Due to Uteri...
Lilly's Cyramza (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Article Link: Lilly’s Cyramza (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer...
FDA Approves Genentech’s Tecentriq in Combination With Avastin for People With Hepatocellular Carcinoma
Article Link: FDA Approves Genentech’s Tecentriq in Combination With Avastin for People With Hepatocellular Carcinoma South San Francisco...
FDA Approves Zilxi (minocycline) Topical Foam for the Treatment of Rosacea
Article Link: FDA Approves Zilxi (minocycline) Topical Foam for the Treatment of Rosacea BRIDGEWATER, N.J., May 29, 2020 (GLOBE NEWSWIRE)...
FDA Approves Tauvid (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer's Disease
Article Link: FDA Approves Tauvid (flortaucipir F 18 injection) for Use in Patients Being Evaluated for Alzheimer’s Disease INDIANA...
FDA Approves New Pediatric Formulation of Sirturo (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
Article Link: FDA Approves New Pediatric Formulation of Sirturo (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidru...
FDA Approves Artesunate for Injection for the Treatment of Severe Malaria
Article Link: FDA Approves Artesunate for Injection for the Treatment of Severe Malaria FREDERICK, Md., May 27, 2020 /PRNewswire/ —...
FDA Approves VESIcare LS (solifenacin succinate) Oral Suspension for Pediatric Patients
Article Link: FDA Approves VESIcare LS (solifenacin succinate) Oral Suspension for Pediatric Patients NORTHBROOK, Ill., May 27, 2020 /PRN...
FDA Approves VESIcare LS (solifenacin succinate) Oral Suspension for Neurogenic Detrusor Overactivity (NDO) Pediatric Patients
Article Link: FDA Approves VESIcare LS (solifenacin succinate) Oral Suspension for Neurogenic Detrusor Overactivity (NDO) Pediatric Patients �...
